CLINICAL_TRIALS
trial_result
· 2011-07-26
Clinical Trial Update: Hydrogen Peroxide and Nitrite Reduction in Exhaled Breath Condensate of COPD Patients [Phase 1]
Summary
Phase 1 study completed evaluating hydrogen peroxide and nitrite reduction in exhaled breath condensate in chronic obstructive pulmonary disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medical University of Lodz | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED